In a patient with chronic kidney disease (eGFR ≥30 mL/min/1.73 m²) and no contraindications, how should sacubitril/valsartan be initiated, what dosing regimen should be used, and how should renal function and potassium be monitored?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 13, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended dose of Entresto (sacubitril/valsartan) in patients with impaired renal function, specifically in terms of estimated Glomerular Filtration Rate (eGFR)?

What is the recommended dosage of sacubitril/valsartan (Angiotensin Receptor-Neprilysin Inhibitor) for a 71-year-old patient with Impaired renal function?

What parameters should be monitored when initiating Entresto (sacubitril and valsartan) therapy?

What is the optimal management plan for a patient with stage 4 CKD (Chronic Kidney Disease), on apixaban, bumetanide, empagliflozin, metoprolol succinate, sacubitril/valsartan, and spironolactone, with controlled blood pressure but mild orthostatic hypotension, and recent initiation of empagliflozin?

What are the dosing adjustments for sacubitril (Angiotensin Receptor-Neprilysin Inhibitor) valsartan in patients with Chronic Kidney Disease (CKD)?

What supplements and medications are recommended for preconception (promil) in a healthy 20‑ to 40‑year‑old couple without chronic medical conditions?

At what size of a cortical skull defect in a pediatric patient with a dermoid cyst eroding through the skull should cranioplasty with bone graft be performed?

Should naloxone be given to a newborn with poor respiratory effort after maternal epidural opioid analgesia?

In a newborn of a mother with untreated or inadequately treated syphilis, how should we evaluate for congenital infection and neurosyphilis, what penicillin regimen is indicated, and what neurodevelopmental surveillance is required?

In a stable patient with chronic kidney disease and heart failure with reduced or mildly reduced ejection fraction, how should sacubitril/valsartan be initiated, what starting dose and titration schedule should be used, and what monitoring and safety precautions are required?

In a child with a dermoid cyst causing a full‑thickness posterior skull table defect, what are the options for bony reconstruction and does the size of the defect influence the management choice?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.